Cargando…

S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS

BACKGROUND: Cognitive dysfunctions have long been observed in patients with schizophrenia, while cognitive symptoms are receiving a lot of attention due to the fact they can be considered core symptoms of schizophrenia. Cerebral blood flow has been by some researchers associated with cognitive funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Peitl, Vjekoslav, Silić, Ante, Ostojić, Draženka, Aukst Margetić, Branka, Markoš, Ines Šiško, Bogović Dijaković, Anamarija, Rendulić, Ana, Karlović, Dalibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234574/
http://dx.doi.org/10.1093/schbul/sbaa031.281
_version_ 1783535795302301696
author Peitl, Vjekoslav
Silić, Ante
Ostojić, Draženka
Aukst Margetić, Branka
Markoš, Ines Šiško
Bogović Dijaković, Anamarija
Rendulić, Ana
Karlović, Dalibor
author_facet Peitl, Vjekoslav
Silić, Ante
Ostojić, Draženka
Aukst Margetić, Branka
Markoš, Ines Šiško
Bogović Dijaković, Anamarija
Rendulić, Ana
Karlović, Dalibor
author_sort Peitl, Vjekoslav
collection PubMed
description BACKGROUND: Cognitive dysfunctions have long been observed in patients with schizophrenia, while cognitive symptoms are receiving a lot of attention due to the fact they can be considered core symptoms of schizophrenia. Cerebral blood flow has been by some researchers associated with cognitive functioning, or at least some aspects of cognitive functions. Because of its distinctive psychopharmacologic properties, aripiprazole is deemed a substantially different antipsychotic compared to the majority of the available compounds. It has been hypothesised that due to this fact it could have beneficial effects especially on cognition in schizophrenia. In line with that thought, the objective of this study was to investigate whether use of an atypical antipsychotic aripiprazole has beneficial effects on cerebral blood flow and cognitive functioning in patients with a first episode of schizophrenia during a three month treatment. METHODS: Forty patients were included in the ongoing study. At baseline and at three month follow up schizophrenia symptomatology was assessed by PANSS, cognitive functions by 5-KOG screening instrument for cognition in psychiatry, while cerebral blood flow was assessed by 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO) using a SPECT technique. RESULTS: After three months of treatment, we observed a significant improvement of schizophrenia symptoms and cognitive functions, measured by PANSS and 5-KOG, with all of the five subscales of the latter and its total score being significantly higher than at baseline (p<0.05). Similarly, cerebral blood-flow measured by SPECT improved at three months follow up compared to baseline. DISCUSSION: Use of aripiprazole in first episode patients with schizophrenia is associated with increased fronto-temporal cerebral blood flow and improvement of schizophrenia symptomatology, including cognition indices. Although we cannot confirm it directly, it is possible that improved fronto-temporal cerebral blood flow led to the improvement in cognition indices.
format Online
Article
Text
id pubmed-7234574
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72345742020-05-23 S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS Peitl, Vjekoslav Silić, Ante Ostojić, Draženka Aukst Margetić, Branka Markoš, Ines Šiško Bogović Dijaković, Anamarija Rendulić, Ana Karlović, Dalibor Schizophr Bull Poster Session I BACKGROUND: Cognitive dysfunctions have long been observed in patients with schizophrenia, while cognitive symptoms are receiving a lot of attention due to the fact they can be considered core symptoms of schizophrenia. Cerebral blood flow has been by some researchers associated with cognitive functioning, or at least some aspects of cognitive functions. Because of its distinctive psychopharmacologic properties, aripiprazole is deemed a substantially different antipsychotic compared to the majority of the available compounds. It has been hypothesised that due to this fact it could have beneficial effects especially on cognition in schizophrenia. In line with that thought, the objective of this study was to investigate whether use of an atypical antipsychotic aripiprazole has beneficial effects on cerebral blood flow and cognitive functioning in patients with a first episode of schizophrenia during a three month treatment. METHODS: Forty patients were included in the ongoing study. At baseline and at three month follow up schizophrenia symptomatology was assessed by PANSS, cognitive functions by 5-KOG screening instrument for cognition in psychiatry, while cerebral blood flow was assessed by 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO) using a SPECT technique. RESULTS: After three months of treatment, we observed a significant improvement of schizophrenia symptoms and cognitive functions, measured by PANSS and 5-KOG, with all of the five subscales of the latter and its total score being significantly higher than at baseline (p<0.05). Similarly, cerebral blood-flow measured by SPECT improved at three months follow up compared to baseline. DISCUSSION: Use of aripiprazole in first episode patients with schizophrenia is associated with increased fronto-temporal cerebral blood flow and improvement of schizophrenia symptomatology, including cognition indices. Although we cannot confirm it directly, it is possible that improved fronto-temporal cerebral blood flow led to the improvement in cognition indices. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7234574/ http://dx.doi.org/10.1093/schbul/sbaa031.281 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Session I
Peitl, Vjekoslav
Silić, Ante
Ostojić, Draženka
Aukst Margetić, Branka
Markoš, Ines Šiško
Bogović Dijaković, Anamarija
Rendulić, Ana
Karlović, Dalibor
S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS
title S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS
title_full S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS
title_fullStr S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS
title_full_unstemmed S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS
title_short S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS
title_sort s215. fronto-temporal cerebral blood flow and cognitive functioning in patients with first episode psychoses treated with aripiprazole: preliminary findings
topic Poster Session I
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234574/
http://dx.doi.org/10.1093/schbul/sbaa031.281
work_keys_str_mv AT peitlvjekoslav s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings
AT silicante s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings
AT ostojicdrazenka s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings
AT aukstmargeticbranka s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings
AT markosinessisko s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings
AT bogovicdijakovicanamarija s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings
AT rendulicana s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings
AT karlovicdalibor s215frontotemporalcerebralbloodflowandcognitivefunctioninginpatientswithfirstepisodepsychosestreatedwitharipiprazolepreliminaryfindings